Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Advent International in connection with its acquisition of a minority interest in Medius
Mandate

Vinge has advised Advent International in connection with its acquisition of a minority interest in Medius

March 17, 2022 Employment and Benefits Banking and Finance M&A Commercial Agreements Intellectual Property

Medius is a global leader in AP automation, payments, sourcing and procurement. The company’s suite of products and services automate the process of receiving, handling, approving, and paying an invoice, and simplify the onboarding and managing of vendors.

Vinge’s team consisted primarily of Christina Kokko, Ulrich Ziche, Isabelle Wållgren, Eléonore Friberg and Elias Bohlin (M&A), Josefine Lanker (Banking & Finance), Mika Jordan (Commercial Agreements), Fredrika Hjelmberg and Karolina Fuhrman (IT/GDPR), Michael Montner (IP), and Veronika Garemark (Employment).

More information on the transaction can be found here. https://www.adventinternational.com/advent-international-to-acquire-minority-stake-in-spend-management-leader-medius/ 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025